Inflammatory mediators and their influence on haemostasis

Area of Science:

• Critical Care Medicine
• Immunology
• Pathophysiology

Background:

• Sepsis is the primary cause of mortality in Intensive Care Units (ICUs).
• Sepsis is characterized as the host's inflammatory response to infection, known clinically as Systemic Inflammatory Response Syndrome (SIRS).
• SIRS involves the activation of immune cells like monocytes/macrophages and neutrophils, and endothelial cells.

Purpose of the Study:

• To elucidate the complex pathophysiological mechanisms underlying sepsis and SIRS.
• To describe the cascade of inflammatory mediator release and its impact on hemostasis.

Main Methods:

• Review of the pathophysiological cascade initiated by endotoxin.
• Analysis of cytokine release, including Tumor Necrosis Factor (TNF), Interferon gamma (IFN gamma), and Interleukins (IL-1, IL-6, IL-8).
• Examination of the effects of inflammatory mediators on hemostasis and fibrinolysis.

Main Results:

• Endotoxin triggers TNF release, modulated by IFN gamma and IL-10, followed by other interleukins.
• Mediators activate the extrinsic coagulation pathway via tissue factor expression.
• Endothelial cell activation increases plasminogen activator inhibitor type 1 (PAI-1), inhibiting fibrinolysis and leading to microvascular fibrin deposition.

Conclusions:

• The intricate mechanisms of SIRS contribute to coagulation activation and fibrinolysis inhibition.
• The highly individualized patient response to sepsis complicates the establishment of universal treatment guidelines.
• Understanding the dynamic nature of SIRS is crucial for managing sepsis.